Use of Enteral Nutrition for the Control of Intestinal Inflammation in Pediatric Crohn Disease

Critch, Jeff*; Day, Andrew S.; Otley, Anthony; King-Moore, Cynthia§; Teitelbaum, Jonathan E.||; Shashidhar, Harohalli#; on Behalf of the NASPGHAN IBD Committee

Erratum

In the article that appeared on page 298 of the February 2012 issue, the article type was given as “Clinical Guideline.” The article type is “Clinical Report.”

Journal of Pediatric Gastroenterology and Nutrition. 54(4):573, April 2012.

Journal of Pediatric Gastroenterology & Nutrition:
doi: 10.1097/MPG.0b013e318235b397
Clinical Guideline
Abstract

ABSTRACT: Exclusive enteral nutrition is an effective yet often underused therapy for the induction of remission in pediatric Crohn disease. The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition formed the Enteral Nutrition Working Group to review the use of enteral nutrition therapy in pediatric Crohn disease. The group was composed of 5 pediatric gastroenterologists and 1 pediatric nutritionist, all with an interest and/or expertise in exclusive enteral nutrition. Specific attention was placed upon review of the evidence for efficacy of therapy, assessment of the variations in care, identification of barriers to its widespread use, and compilation of the necessary components for a successful program. The present guideline is intended to aid physicians in developing an enteral nutrition therapy program and potentially promote its use.

Author Information

*Division of Gastroenterology, Janeway Children's Health Center, Memorial University, St John's, Newfoundland and Labrador, Canada

Department of Paediatrics, University of Otago, Christchurch, NZ

Division of Gastroenterology and Nutrition, IWK Health Centre and Dalhousie University

§Pediatric Gastroenterology, IWK Health Centre, Halifax, Nova Scotia, Canada

||Division of Pediatric Gastroenterology and Nutrition, Children's Hospital at Monmouth Medical Center, Long Branch, NJ

#Department of Pediatrics, Division of Pediatric Gastroenterology and Nutrition, University of Kentucky Medical Center, Lexington, KY.

Address correspondence and reprint requests to Dr Jeff Critch, Division of Gastroenterology, Janeway Children's Health Center, Memorial University, 300 Prince Philip Dr, St John's, Newfoundland and Labrador A1B 3V6, Canada (e-mail: jeff.critch@easternhealth.ca).

Received 15 June, 2011

Accepted 1 September, 2011

J.C. serves on the speakers’ bureaus of Mead Johnson Canada and Schering Canada, and is a member of the advisory board of Abbott Pharmaceuticals Canada; A.S.D. is a member of the MSD advisory board; A.O. is a site investigator for Centocor and UCB, serves on the speakers’ bureaus of Mead Johnson Canada, Schering Canada, and Nestlé Canada, and is a member of the advisory board of Abbott Pharmaceuticals Canada; J.E.T. is a member of the advisory boards of Danonino and Dannon Yogurt.

Copyright 2012 by ESPGHAN and NASPGHAN